Tong KB - Search Results

1

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Paller AS, Stevens SR, Whitaker-Worth DL, Tong KB. Ellis CN, et al. Among authors: tong kb. J Am Acad Dermatol. 2003 Apr;48(4):553-63. doi: 10.1067/mjd.2003.240. J Am Acad Dermatol. 2003. PMID: 12664019

2

Cost of atopic dermatitis and eczema in the United States.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Ellis CN, et al. Among authors: tong kb. J Am Acad Dermatol. 2002 Mar;46(3):361-70. doi: 10.1067/mjd.2002.120528. J Am Acad Dermatol. 2002. PMID: 11862170

3

Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Tong KB. Ellis CN, et al. Among authors: tong kb. Pharmacoeconomics. 2003;21(12):875-83. doi: 10.2165/00019053-200321120-00004. Pharmacoeconomics. 2003. PMID: 12908843

4

Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Abramovits W, Hung P, Tong KB. Abramovits W, et al. Among authors: tong kb. Am J Clin Dermatol. 2006;7(4):213-22. doi: 10.2165/00128071-200607040-00002. Am J Clin Dermatol. 2006. PMID: 16901181 Review.

5

Quantifying costs associated with atopic dermatitis.

Ellis CN, Prendergast MM, Tokar M, Tong K. Ellis CN, et al. J Manag Care Pharm. 2003 May-Jun;9(3):278; author reply 278-9. doi: 10.18553/jmcp.2003.9.3.278. J Manag Care Pharm. 2003. PMID: 14613475 Free PMC article. No abstract available.

6

Prevalence of hypertension among patients with atopic dermatitis.

Abramovits W, Stevenson L, Prendergast MM, Tong K. Abramovits W, et al. Br J Dermatol. 2003 Feb;148(2):380; author reply 380. doi: 10.1046/j.1365-2133.2003.05097_15.x. Br J Dermatol. 2003. PMID: 12588411 No abstract available.

7

The economics of topical immunomodulators for the treatment of atopic dermatitis.

Abramovits W, Boguniewicz M, Paller AS, Whitaker-Worth DL, Prendergast MM, Tokar M, Tong KB. Abramovits W, et al. Among authors: tong kb. Pharmacoeconomics. 2005;23(6):543-66. doi: 10.2165/00019053-200523060-00003. Pharmacoeconomics. 2005. PMID: 15960552 Review.

8

A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis.

Boguniewicz M, Abramovits W, Paller A, Whitaker-Worth DL, Prendergast M, Cheng JW, Wang P, Tong KB. Boguniewicz M, et al. Among authors: tong kb. J Drugs Dermatol. 2007 Apr;6(4):416-23. J Drugs Dermatol. 2007. PMID: 17668539 Clinical Trial.

9

Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.

Prendergast MM, Abramovits W, Boguniewicz M, Lebwohl M, Tokar M, Tong KB. Prendergast MM, et al. Among authors: tong kb. J Invest Dermatol. 2004 Sep;123(3):452-4. doi: 10.1111/j.0022-202X.2004.09116.x. J Invest Dermatol. 2004. PMID: 15304081 Free article. Review.

10

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Cagnoni PJ, Walsh TJ, Prendergast MM, Bodensteiner D, Hiemenz S, Greenberg RN, Arndt CA, Schuster M, Seibel N, Yeldandi V, Tong KB. Cagnoni PJ, et al. Among authors: tong kb. J Clin Oncol. 2000 Jun;18(12):2476-83. doi: 10.1200/JCO.2000.18.12.2476. J Clin Oncol. 2000. PMID: 10856108 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page